Search
for
Sort by
Research 31–60 of 103
- Janus Kinase inhibitors in dermatology: a review
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Novel drugs of United States Food and Drug Administration approved in 2024
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Alopecia areata, actualización clínica y terapéutica
- Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
- Lipid nanocarriers as innovative strategies for hair regrowth
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Journal of Population Therapeutics and Clinical Pharmacology
- Baricitinib: A Review in Severe Alopecia Areata
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Dermatological Indications: Alopecia Areata
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Application of Baricitinib in Dermatology
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Alopecia Areata: Current Treatments and New Directions